ABSTRACT
MATERIALS AND METHODS
Generation of PS-cDKO mice was achieved at the animal facility at Harvard Medical School. We crossed floxed PS1 (fPS1), ␣CaMKII-Cre transgenic (Yu et al., 2001) , and PS2؊/؊ (Steiner et al., 1999) mice together to obtain fPS1/fPS1; ␣CaMKII-Cre; PS2؊/؊ mice. Four PS-cDKO mice, derived from two litters, were used for the EM study. For controls, two genotypes of mice were used: one was the fPS1 (three mice), which were floxed but otherwise of the same genotype as wildtype (WT) and expressed both PS1 and PS2. The other control was the PS2؊/؊ (two mice), from which the PS2 gene was deleted but the PS1 gene was retained. Neither of these controls exhibit histological abnormalities, as assessed by light microscopy. Their memory is also intact, based on the performance in the Morris water maze to assess spatial memory or contextual fear conditioning, used to assess associative memory . Importantly, none of the animals that underwent EM-ICC analyses had been used for behavioral studies antemortem, so as to avoid inducing any change in synaptic proteins as a consequence of experience.
Antibody information, antibody characterization, and related immunoreagents
The antibody directed against the NR2A subunit of NMDARs was purchased from Upstate Biotechnology (Lake Placid, NY, Cat. No. 07-632). The antibody was produced in rabbits and was directed against amino acids 1265-1464 of the C-terminus of mouse NR2A subunit. Specificity of this antibody has been demonstrated previously by Western blot (manufacturer's datasheet) and confirmed in subsequent publications (Rinaldi et al., 2007) , which show that this antibody recognizes a single band corresponding to Ϸ170 kD, the molecular weight of NR2A subunits. The antibody directed against the NR2B subunit of NMDARs was produced in rabbits and directed to the C-terminal 20 amino acids of mouse NR2B (KFNGSSNGHVYEKLSSIESDV). This antibody was also purchased from Upstate Biotechnology (Cat. No. 06-600) and has been shown to not crossreact with the NR2A or NR1 subunits of NMDARs (Rinaldi et 
Preparation of brain tissue for light and electron microscopy
Mice were euthanized by transcardial perfusion with fixatives at the laboratory of Jie Shen, Harvard Medical School, while the postmortem preparation of tissue for EM-ICC was performed in the laboratory of Chiye Aoki, New York University (NYU).
At the age of 8 weeks postnatal, mice were deeply anesthetized using Nembutal (50 mg/kg i.p.), then euthanized by transcardial perfusion with fixatives. A peristaltic pump was used to control the flowrate of the perfusates to 10 -50 mL/ min. The perfusates were the following: 1) 10 -50 mL of saline containing heparin (1,000 U/mL), over a 1-minute period; 2) 200 mL of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). No other aldehydes were added to the perfusate. This omission was intentional, to avoid overfixation of the tissue during the shipment from Harvard to NYU. Previous studies have shown that tissue postfixed with glutaraldehyde after the immunocytochemical procedure but before fixation with osmium tetroxide provides adequate preservation of ul-trastructure and antigenicity for most immunocytochemical procedures.
All steps of this procedure were in accordance with the protocol approved by the University Animal Welfare Committee of Harvard Medical School and in full conformance with the recommendations of the 1996 edition of the NIH Guide for the Care and Use of Laboratory Animals and all applicable Federal, State, and local laws, and as outlined in the NIH the principles for use of animal (NIH Manual Chapter 4206).
Following this perfusion, brains were removed from the skull, then immersed in the same fixative while shipped on ice to the Aoki laboratory at NYU. Within 1 day following the perfusion, the brain was cut into 40-m-thick coronal sections using a vibratome. Subsequently, the sections were stored for up to 1 month, free-floating at 4°C in 0.01 M PB with 0.9% sodium chloride (PBS, set to pH 7.4) containing 0.05% sodium azide.
NR2A/NR2B immunocytochemistry and the rationale for the use of the two immunolabels
Immunocytochemistry was performed to immunolabel the NR2A subunits of NMDAR using two EM-ICC procedures as described previously (Aoki et al., 2000) . In brief, the HRP-DAB procedure was used to optimize detection of immunolabels within spines. Immunolabels were applied on free-floating vibratome sections, prior to embedding in the plastic resin, EM812, using 3,3-diaminobenzidine and H 2 O 2 as substrates (HRP-DAB). The NR2A antibody was used at a concentration of 1 g/mL, incubated overnight at room temperature under constant agitation, using PBS (pH 7.6) as a diluent, together with 1% BSA and 0.05% sodium azide. Following this incubation, sections were rinsed in PBS for 1 hour at room temperature, then immersed in the secondary antibody solution. The secondary antibody, goat antirabbit IgG, was applied to the sections for 1 hour at room temperature under constant agitation at a dilution of 1:100, using PBS-BSA with 0.05% sodium azide as the diluent. The avidin-biotin-peroxidase complex was prepared according to the manufacturer's specifications-i.e., by suspending 2 drops of solution A and 2 drops of solution B in 5 mL of PBS over a period of 30 minutes prior to application. After rinsing the vibratome sections in PBS, the sections were incubated in this ABC solution for 30 minutes, then rinsed in PBS, before immersing them in the HRP substrate of 3,3-diaminobenzidine and H 2 O 2 . The HRP reaction was allowed to proceed for 10 minutes and terminated by rinsing the sections in PBS. The HRP-DAB labeled sections were postfixed with 1% glutaraldehyde and 1% osmium tetroxide. All of these steps were performed identically for all of the sections collected from the control and PS-cDKO brains, by performing all steps of the ABC reaction strictly in parallel, so as to ensure that all immunoreagents, incubation periods, rinses, and HRP-reaction times were identical.
The other immunolabeling procedure was PEG (postembed immunogold labeling), used to quantify the level of immunolabeling directly over the postsynaptic densities (PSDs) versus other sites within spine heads that are removed from the PSD. Vibratome sections designated for this procedure were fixed in the absence of osmium tetroxide (Phend et al., 1995) so as to retain antigenicity of NR2As. The tissue was embedded in EPON812, and the ultrathin sections were processed with modifications described specifically for PEG-labeling of NR2A subunits (Erisir and Harris, 2003) . Specifically, the concentration of the anti-NR2A antibody was 10 g/mL, while the concentration of the secondary antibodies-10 nm goldconjugated antirabbit IgG antibodies-was 1:100. As described for the HRP-DAB-labeled material, all of the PEG procedures for all ultrathin sections were performed in parallel, so as to ensure that all reagents, incubation periods, and rinses were performed identically across the control and PScDKO tissue.
The NR2B subunit of NMDARs was also probed within spines by the same PEG procedure, but using the anti-NR2B antibody at a concentration of 10 g/mL.
Immunocytochemical controls
Each EM-ICC procedure was accompanied by controls. These consisted of the verification that omission of the primary antibody or use of secondary antibodies that were mismatched for species yielded no immunolabeling that could be detected by light or electron microscopy. To verify the extent of background labeling by the PEG procedure, we sampled 400 asymmetric synapses from two control and two PS-cDKO hippocampi and tallied the frequency of PEG located at synapses. In the absence of the primary antibody, only one exhibited PEG labeling over the postsynaptic density and two exhibited PEG labeling at the presynaptic membrane. The remaining synapses exhibited no PEG labeling at all. Besides these controls, electron microscopic examination revealed that, in the presence of primary antibodies, the NR2A or NR2B-immunolabeling of the hippocampus of PS-cDKO and control brains never occurred postsynaptic to symmetric (presumably inhibitory) synapses, as was observed previously in rodent brain tissue ( 
Digital capturing of electron microscopic images and areas sampled
All persons capturing images were kept blind to the genotype of the animal, so as to eliminate bias in sampling of neuropil. Images used for quantitative analyses were captured digitally using a Hamamatsu CCD camera and software developed by AMT (Boston, MA), attached to a JEOL 1200XL electron microscope. Images were digitally captured at a magnification of 50,000؋ for PEG-immunolabeled tissue, 40,000؋ for HRP-DAB immunolabeled tissue, and at 20,000؋ for synapse density analysis. The anatomical region was verified to be the stratum radiatum in the CA1 field of the hippocampus by sweeping the ultrathin sections at a magnification of 4,500؋. At this magnification, immunolabeling cannot be resolved. This magnification was chosen so that our choice of the region to be sampled would not be biased by the level of overall immunolabeling.
All micrographs used for quantitative analyses were taken from regions of the neuropil that fulfilled the following criteria. 1) The neuropil resided approximately midway within stratum radiatum of CA1 within the dorsal blade of the hippocampus. This anatomical region was displaced from the base of the pyramidal cell layer by at least 50 m and was also removed from stratum lacunosum-moleculare by Ϸ50 m. Under the electron microscope, it was evident that the middle portion of stratum radiatum was clearly removed from the portion of the
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neuropil traversed by the large, proximal portions of the apical dendrites of CA1 pyramidal neurons. 2) For the HRP-DABlabeled tissue, only the neuropil was required to reside within portions of vibratome sections forming the razor-blade-cut surface, where penetration of immunoreagents into the vibratome sections would be maximal. For PEG-immunolabeled tissue, the neuropil resided within portions of vibratome sections that were removed from the surface, so as to avoid sampling of neuronal profiles that were less than the full thickness of the ultrathin sections. For both labeling approaches, sampling of stratum radiatum spanned multiple ultrathin sections collected on multiple grids and traversing distances greater than 200 m laterally and at least 100 m dorsoventrally.
Quantitative electron microscopic analyses
For all parts of the quantitative analyses that were performed offline, the person performing the tallying was kept blind to the genotype of the animal. Systematic sweeps were made across the tissue to digitally capture the synaptic neuropil. Within 2D digitized images, synapses were identified as asymmetric and Gray type 1, based on the presence of thick PSDs that aligned the intracellular surfaces of plasma membranes abutting vesicle-filled axon terminals. These asymmetric (presumably excitatory; Kennedy and Ehlers, 2006) synapses were numbered in the order encountered. Each asymmetric synapse was subsequently categorized as being associated with or without NR2A or NR2B immunolabel. On some of the images the contrast of the digital image was varied to facilitate detection of NR2A/B labels that resided directly over the PSD using Adobe Photoshop (v. 7.0, San Jose, CA).
For HRP-DAB and especially for the PEG-labeled tissue, the immunolabeling was sufficiently discrete to allow discrimination of the immunoreactive sites as synaptic or nonsynaptic. For PEG-labeled tissue, the position of immunolabel was categorized as being at the PSD, if the immunolabeling was directly over the PSD ('at PSD') or in the synaptic cleft. These categorizations correspond to Bins 1-3 and 5, respectively, of Yildirim et al. (2008) . Labeling that occurred within a distance equal to twice the thickness of the PSD in its plane of section were categorized as 'near PSD,' while those within the spine head but removed from the PSD by a distance greater than twice the thickness of the PSD was categorized as nonsynaptic but 'In Spine. To quantify the frequency of immunolabeling for NR2A labeling, an equal number of synapses were analyzed from each animal. For the HRP-DAB-labeled material, the number of synapses associated with immunolabel was tallied for every group of 10 synapses that were encountered. This tallying was repeated exactly 11 times for each animal (i.e., reflecting analysis of 110 synapses per animal, and repeated for each of the five control genotype brains and four PS-cDKO brains). The mean and standard error of the mean (SEM) of the percent of labeled synapses (per 10 synapses) for each genotype group were calculated and subjected to the unpaired t-test. 
Analysis of the frequency of encounter with synapses per unit area
The ultrathin sections prepared to determine NR2A-immunoreactivity were reexamined and recaptured digitally at a lower magnification (20,000؋) to determine the frequency of encounter with synaptic profile within ultrathin sections collected from the stratum radiatum of the CA1 field. Synapse encounter frequency was determined by calculating the mean of the number of synaptic profiles captured in each electron 2 ). Portions of the neuropil containing blood vessels or somata were excluded from synapse encounter frequency calculations using Image J (NIH, Bethesda, MD) to estimate such areas. Portions of the ultrathin sections containing no neuropil (i.e., EPON resin only) were also excluded for calculating synapse encounter frequency. Since the synapse encounter frequency varied 4-fold within any single animal's stratum radiatum in a fashion that was strongly influenced by the laminar position, relative to the PCL and SLM (Fig. 7) , six consecutively collected micrographs positioned roughly equidistant from the PCL and SLM (Ϸ60 m from either strata) were used to derive the mean and SEM of synapses per unit area for each animal, and the average values of each animal were compared across genotypes.
Statistical analyses
All statistical analyses were performed using the software Statistica (v. 6.0, Statsoft, Tulsa, OK) and confirmed using another software, SPSS (v. 15.0, Chicago, IL). When comparing data across the two genotypes, Student's t-test was used. Significance was accepted for P-values less than 0.05.
Capturing and reproduction of figures
Electron microscopic images were captured and stored using the CCD camera attached to a JEOL 1200XL via software developed by AMT. Light microscopic images were captured at a magnification of 5؋ using a CCD camera attached to a Zeiss Axiophot microscope. For reproduction, a subset of these images were adjusted in contrast, brightness, and image size using Adobe Photoshop (v. 7.0).
RESULTS

LM reveals no overt difference in the hippocampus of control and PS-cDKO
Previous studies have indicated that PS-cDKO brains exhibit signs of inflammation and neurodegeneration but that these changes are not yet apparent at 2 months of age . Light microscopy was performed to determine whether any changes might be detectable by Nissl staining. As expected, no overt difference was noted (Fig. 2) .
EM-ICC using HRP-DAB labels reveals an augmentation of the proportion of spines immunoreactive for the NR2A subunits within PS-cDKO hippocampi
At 2 months of age, mice lacking both PS1 and PS2 exhibit impairment in spatial memory, as assessed by the increased escape latency and path lengths that these animals exhibit in finding the hidden platform of the Morris water maze. These behaviors were categorized as mild memory impairment, since the animals still exhibit improvements in their performance over the course of 5 training days (Saura et al., 2004) . To determine whether this mild form of spatial memory impairment could be due to decreased levels of NMDARs at synapses of the hippocampus, the asymmetric synapses formed on apical dendrites of the CA1 pyramidal neurons were assessed for the presence of the NR2A and NR2B subunits of NMDARs.
HRP-DAB was used so as to optimize detection of immunoreactivity anywhere within dendritic spines in stratum radiatum of the CA1 field of four PS-cDKO and five agematched control animals. EM-ICC revealed that both the control and PS-cDKO brains exhibit NR2A immunolabeling along thick PSDs and at plasmalemmal sites within spines that are removed from the active zone (Fig. 3) . In contrast, symmetric synapses with thin PSDs were devoid of immunoreactivity, as were many thick PSDs in the immediate vicinity.
Quantification of the population of asymmetric synapses within the stratum radiatum of CA1 (110 per animal, altogether 550 from control tissue and 440 from PS-cDKO tissue) exhibiting NR2A-immunoreactivity revealed that NR2A immunolabeling is not reduced within the hippocampus of PS-cDKO mice. On the contrary, the proportion of asymmetric synapses immunolabeled for NR2A is augmented by 28% within the hippocampus of PS-cDKO mice, relative to the hippocampus of controls (P < 0.05; unpaired t-test, t-value ‫؍‬ ؊2.34; Fig.  3A ). (Fig. 5A) . This difference was statistically significant (P < 0.05, t ‫؍‬ ؊2.40, unpaired t-test). Further analysis of the synaptic NR2A-labeling revealed that the difference across genotypes resided precisely within the region of synapses that are 0 -30 nm from the intracellular surface of the plasma membrane (Bin 1 of Yildirim et al., 2008) . In this region the PEG level was 31% higher for the PS-cDKO synapses, relative to control synapses, and this difference was statistically significant (P ‫؍‬ 0.006, t ‫؍‬ ؊2.74). In contrast, NR2A labeling in Bin 2 (30 -60 nm from the postsynaptic membrane) was much less than in Bin 1 (0.10 ؎ 0.02 for controls; 0.13 ؎ 0.02 for PScDKO) and not significantly different across the two genotypes (P ‫؍‬ 0.21, t ‫؍‬ ؊1.26).
CA1 of hippocampus of PS-cDKO brains, relative to those of control
The levels of nonsynaptic NR2As, as assessed by counting the PEG particles residing within spines but removed from PSDs, differed across the two genotypes but in the opposite direction. PEG particles were fewer at nonsynaptic sites within spines of PS-cDKO synapses relative to controls. Even after normalizing for the overall levels of PEG particles within postsynaptic spines, the levels of PEG at nonsynaptic sites was reduced by 24% in the PS-cDKO CA1 (t-value ‫؍‬ 2.57; P < 0.05; Fig. 5B) . Importantly, the average total PEG level within postsynaptic spines (synaptic plus nonsynaptic) was not significantly different across the two genotypes (t-value ‫؍‬ ؊1.22; P ‫؍‬ 0.22).
NR2B levels at synapses of PS-cDKO hippocampi remain unchanged
In the hippocampus, NMDARs can occur as heteromers with NR2B subunits. To determine whether PS-cDKO leads to reduction of NR2B subunits, spines of the same hippocampal tissue were immunolabeled for the NR2B subunits. EM-ICC revealed that NR2B subunits also occur synaptically and nonsynaptically and are more prevalent presynaptically than are the NR2A-subunits (Fig. 6) . Analysis of 800 synapses residing within the CA1 field of four PS-cDKO and four control animals (i.e., 200 synapses per animal) revealed that NR2B levels are identical across the two groups, both at synapses (unpaired t-test, t-value ‫؍‬ ؊0.085, P ‫؍‬ 0.932) and at nonsynaptic sites within spines (Fig. 5D,E) (unpaired t-test t-value ‫؍‬ ؊0.364; P ‫؍‬ 0.717). NR2A is elevated both pre-and postsynaptically in the PS-cDKO hippocampus but NR2B levels are unchanged. For the NR2A-subunit analysis, synapses from three control animals and four PS-cDKO animals were analyzed, sampling exactly 200 synapses from each animal. Therefore, the n-value was 600 for the controls and 800 for the PS-cDKO group. PEG quantification reveals that NR2A subunits are significantly elevated at and near the PSD (A) and in presynaptic axon terminals (C). In contrast, the NR2A labeling is significantly reduced at sites removed from the PSD of spines in the CA1 of PS-cDKO brains (B). *P < 0.05; **P < 0.0005. Analysis of NR2B immunolabeling was performed across synapses from four control animals and four PS-cDKO animals. Exactly 100 synapses were sampled from each animal. Therefore, the n-value was 400 for both groups. The NR2B-PEG analysis revealed no difference at postsynaptic (D), presynaptic (F) or nonsynaptic (E) domains of asymmetric synapses.
Presynaptic NR2A and NR2B
We therefore extended our PEG analysis to presynaptic axon terminals. The results indicated a pattern parallel to that described for the postsynaptic NR2 subunits, namely, a 36% increase of NR2A subunits within axon terminals forming asymmetric synapses onto dendritic spines of the PS-cDKO hippocampus, relative to the frequency observed for agematched controls (Fig. 5C ) (t-value ‫؍‬ ؊3.632; P < 0.0005). No difference in the presynaptic NR2B levels was detected across the two groups (Fig. 5C,F) (unpaired t-test, t-value ‫؍‬ 0.356; P ‫؍‬ 0.721).
When the primary antibody was omitted from the PEG procedure, only two asymmetric synapses out of 400 were associated with PEG presynaptically. The number of PEG particles associated with these presynaptic membranes was 1 for both cases. This outcome indicates that nonspecific binding of secondary antibodies to ultrathin sections is negligible.
Comparison of the encounter frequency with axospinous synapses in stratum radiatum of the CA1 reveals a small difference Earlier studies had shown that the synaptic currents in the CA1 field carried by the NMDARs are reduced within PS-cDKO brains and that this phenotype is evident by the second postnatal month. To determine whether the reduction of NMDAR-currents may be explained by a reduction of excitatory synapses, rather than the strength of individual synapses, we compared the relative density of axospinous asymmetric (presumably excitatory) synapses within stratum radiatum of the CA1 of the PS-cDKO and control mice. The same ultrathin sections that were collected for the analysis of NR2A-PEG immunolabeling were examined to collect a series of electron microscopic 2D images spanning the stratum radiatum of the dorsal CA1 from the PCL to the SLM.
Nineteen to 35 images at a magnification of 20,000؋ were required to tile the strata spanning from the most proximal to the most distal portions of the apical dendrites of the CA1 pyramidal cells. As shown in an example for one PS-cDKO and control tissue (Fig. 7) (P ‫؍‬ 0.40; 251 ؎ nm for control; 264 ؎ 10 nm for the PS-cDKO) or distribution pattern of spine widths (Fig. 8B) . The lack of difference in spine widths indicates that the apparent augmentation in the frequency of encounter with synaptic profiles within the PS-cDKO tissue could not be ascribed to the enlargement of individual spines. 
DISCUSSION
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